Developing Tumor Radiosensitivity Signatures Using LncRNAs | Citedby Results | Radiation Research

Skip to Main Content

Skip Nav Destination

Developing Tumor Radiosensitivity Signatures Using LncRNAs

Radiat Res (2021) 195 (4): 324–333.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

(-) - Epicatechin regulates LOC107986454 by targeting the miR-143–3p/EZH2 axis to enhance the radiosensitivity of non-small cell lung cancer

Meifang Huang
Junfeng Wang
Huahua Zhou
Zengbo Lv
Tianqian Li
Meiyan Liu
Yaqing Lv
Anao Wu
Jie Xia
Hongying Xu
Weiwen Chen
Peiwan Liu

The American Journal of the Medical Sciences (2024) 368 (5): 503.

Clinical Biomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy: A Systematic Review

Christopher W. Bleaney
Hebatalla Abdelaal
Mark Reardon
Carmel Anandadas
Peter Hoskin
Ananya Choudhury
Laura Forker

Cancers (2024) 16 (10): 1942.

Long non-coding RNAs: regulators of autophagy and potential biomarkers in therapy resistance and urological cancers

Shizong Wang
Yang Bai
Jie Ma
Liang Qiao
Mingqing Zhang

Frontiers in Pharmacology (2024) 15

Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity

Zhiru Gao
Qian Zhao
Yiyue Xu
Linlin Wang

Radiation Oncology (2023) 18 (1)

Towards Data Driven RT Prescription: Integrating Genomics into RT Clinical Practice

Javier F. Torres-Roca
G. Daniel Grass
Jacob G. Scott
Steven A. Eschrich

Seminars in Radiation Oncology (2023) 33 (3): 221.

Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies

Amirreza Mehmandar-Oskuie
Kasra Jahankhani
Arman Rostamlou
Sepideh Arabi
Zahra Sadat Razavi
Amirhossein Mardi

Biomedicine & Pharmacotherapy (2023) 165: 115242.

lncRNA-mediated ceRNA network in bladder cancer

Kun Li
Tongyue Yao
Ziqiang Wang

Non-coding RNA Research (2023) 8 (2): 135.

Response to Mistry: Radiosensitivity index is not fit to be used for dose adjustments: A pan-cancer analysis

J.F. Torres-Roca
S.A. Eschrich
M.W. Kattan
J.G. Scott

Clinical Oncology (2023) 35 (9): 621.

Predicting tumour radiosensitivity to deliver precision radiotherapy

James M. Price
Asmithaa Prabhakaran
Catharine M. L. West

Nature Reviews Clinical Oncology (2023) 20 (2): 83.

The Radiosensitivity Index Gene Signature Identifies Distinct Tumor Immune Microenvironment Characteristics Associated With Susceptibility to Radiation Therapy

G. Daniel Grass
Juan C.L. Alfonso
Eric Welsh
Kamran A. Ahmed
Jamie K. Teer
Shari Pilon-Thomas
Louis B. Harrison
John L. Cleveland
James J. Mulé
Steven A. Eschrich
Heiko Enderling
Javier F. Torres-Roca

International Journal of Radiation Oncology*Biology*Physics (2022) 113 (3): 635.

Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis

Jacob G Scott
Geoffrey Sedor
Patrick Ellsworth
Jessica A Scarborough
Kamran A Ahmed
Daniel E Oliver
Steven A Eschrich
Michael W Kattan
Javier F Torres-Roca

The Lancet Oncology (2021) 22 (9): 1221.

Role of Mitochondria in Radiation Responses: Epigenetic, Metabolic, and Signaling Impacts

Dietrich Averbeck
Claire Rodriguez-Lafrasse

International Journal of Molecular Sciences (2021) 22 (20): 11047.

Radiotherapy with genomic-adjusted radiation dose – Authors' reply

Jacob G Scott
Geoffrey Sedor
Jessica A Scarborough
Michael W Kattan
Javier F Torres-Roca

The Lancet Oncology (2021) 22 (11): e470.